Retatrutide is already being called the next generation of medical weight loss, more powerful than Ozempic, Wegovy, or Mounjaro, and patients are actively trying to get their hands on it. There's just one problem: it isn't FDA-approved.
Joshua C. Kreithen, MD, board-certified plastic and body contouring surgeon at Holcomb Kreithen Plastic Surgery & Medspa in Sarasota, believes patients deserve the full picture before making any decisions. This blog covers what retatrutide is, how it compares to approved medications, and why the gray market around it carries real risk.
What Is Retatrutide?
Retatrutide is an investigational once-weekly injectable developed by Eli Lilly for obesity, type 2 diabetes, and related metabolic conditions. It belongs to the same class as semaglutide and tirzepatide, but targets more receptors than either of them.
Semaglutide acts on one (GLP-1). Tirzepatide targets two (GLP-1 and GIP). Retatrutide activates all three:
- GLP-1, which helps regulate appetite, fullness, insulin release, and blood sugar
- GIP, which plays a role in insulin signaling, metabolism, and appetite
- Glucagon, which may increase energy expenditure and support fat metabolism
Early phase 3 trial data reported an average weight loss of 28.7% at 68 weeks, a figure that would represent a meaningful jump beyond current options. Those numbers have generated real excitement. But clinical trial results and real-world readiness are different things.
Why Retatrutide Isn't Available Yet
FDA approval requires a medication to demonstrate safety, efficacy, consistent dosing, proper manufacturing, and appropriate labeling. Retatrutide has not completed that process. There is no approved product, no approved dosing schedule, and no standard pharmacy supply chain. Eli Lilly's own materials describe it as investigational.
The Risk of Compounded or "Research" Retatrutide
Demand has already produced a gray market. Retatrutide is being sold as "research peptides," through wellness platforms, and via compounding pharmacies. None of it is legal for routine human use. The FDA has warned that retatrutide cannot be legally used in compounding under federal law. Products sold through these channels may carry serious risks:
- Incorrect or inconsistent dosing
- Contamination or impurities
- Improper storage conditions
- Unverified active ingredients
- No physician oversight or safety monitoring
Medications in this class affect appetite, blood sugar, digestion, hydration, and gallbladder function. They require medical supervision. A vial purchased online with no verified source and no regulatory oversight is not equivalent to a properly prescribed, monitored treatment.
What Patients Can Do Right Now
Proven options already exist. The clinical team at Holcomb Kreithen Plastic Surgery & Medspa currently offers medically supervised weight-loss treatment using semaglutide and tirzepatide. These work best alongside a structured plan for nutrition, protein intake, resistance training, and sustainable lifestyle change. The goal is improved body composition and lasting metabolic health, not just a lower number on the scale.
Significant weight loss can also raise new aesthetic concerns, such as loose skin, facial volume loss, or changes in body contour. As a plastic surgery and medspa practice, the team at Holcomb Kreithen is well placed to address those changes at the right time, through non-surgical skin tightening, body contouring, injectables, or surgical procedures once weight has stabilized.
Medically Supervised Weight Loss in Sarasota
Retatrutide may prove to be a meaningful advancement, but outside a legitimate clinical trial, it remains unproven, unregulated, and in many cases illegally compounded. Dr. Kreithen's approach to weight loss follows the same standard that guides every procedure at Holcomb - Kreithen Plastic Surgery & Medspa: evidence-based, medically supervised care focused on long-term results. Contact the Sarasota office to schedule a consultation.
by Joshua C. Kreithen, MD – Board-Certified Plastic Surgeon
Joshua C. Kreithen, MD, is a board-certified plastic surgeon at Holcomb Kreithen Plastic Surgery and MedSpa in Sarasota, Florida. With advanced training in aesthetic plastic surgery, Dr. Kreithen is recognized for his expertise in breast and body contouring, mommy makeover, and comprehensive cosmetic surgery of the body after weight loss.
Known for his surgical precision and patient-focused approach, Dr. Kreithen combines artistic vision with the latest techniques to help patients achieve natural, balanced, and lasting results. From breast augmentation and lifts to body sculpting procedures such as liposuction and abdominoplasty, he customizes each treatment plan to the individual’s goals and anatomy.
Dr. Kreithen has earned a reputation for excellence in both surgical outcomes and compassionate care. Patients choose him not only for his technical skill, but also for his dedication to safety, innovation, and personalized attention—qualities that make him a trusted choice for those seeking transformative, confidence-boosting results in Sarasota and beyond.